2018 Australasian Genomic Technologies Association conference
The Australasian Genomic Technologies Association (AGTA) conference, Australia’s foremost genomic technology conference, is an essential event for researchers and industry representatives who work with genomic technologies in a variety of contexts including platform development, medical genomics, functional genomics, non-model systems, epigenomics and plant genomics.
What: The 18th annual AGTA conference
Where: Stamford Grand Hotel in Glenelg, Adelaide
When: 4–7 November 2018
The AGTA conference covers all aspects of genomic science, technologies and their applications. This year’s event will cover a range of topics including cancer genomics, neurogenetics, bioinformatics, computational biology, plant and animal genomics, microbial and meta genomics, ancient DNA as well as highlights of emerging genomic technologies. The AGTA meeting attracts a diverse range of participants including researchers, service providers, industry representatives and students. The conference offers an important opportunity for computational biologists, bioinformaticians and data visualisation specialists to interact with technologists and biologists. This unique mix is one of the reasons that the Australian genomics community has a dynamic cross-disciplinary and innovative approach to genomic analysis, and is at the forefront of analysis tools for new types of ‘omics’ data.
Confirmed keynote speakers include:
- Elizabeth Dinsdale, San Diego State University
- Daniel Geschwind, University of California, Los Angeles
- Jim Haseloff, University of Cambridge
- Ludovic Orlando, University of Copenhagen
- Taru Tukiainen, University of Helsinki
- Kevin White, The University of Chicago
- Marlon Stoeckius, New York Genome Center
- Jacqueline Batley, The University of Western Australia
- Nicole Cloonan, University of Auckland
- Michael McDonald, Monash University
- Gene Tyson, The University of Queensland
- Nic Waddell, QIMR Berghofer
- Sally Ann Harbison, ESR
- Ryan Lister, The University of Western Australia
- Naomi Wray, The University of Queensland
The need for quality assurance in histopathology laboratories
In histopathology laboratories, where tests are considered the gold standard for diagnosing...
Avoid adverse regulatory action with comprehensive quality
Attention to detail is par for the course within most modern industries and fields, including...
The politics of health: how elections will impact on life sciences
With elections this year in the US, the UK and India — all major players in the life...
